Citadel Advisors LLC 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 352,217 8.400% |
-28,947 (-7.59%) |
Filing |
| 2022-02-14 06:30 am Sale |
2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 381,164 9.000% |
-222 (-0.06%) |
Filing |
| 2021-05-21 4:08 pm Purchase |
2021-05-11 | 13G | Talaris Therapeutics, Inc. TALS |
Citadel Advisors LLC | 381,386 9.200% |
381,386 (New Position) |
Filing |